Why Gene Therapy Is Still So Hard to Manufacture at Scale | Phillip Ramsey
Why is gene therapy still so difficult to manufacture at scale after decades of progress? Phillip Ramsey, Chief Technical Officer at Sangamo Therapeutics, joins BioTalk Unzipped for a candid conversation about one of the
















